Rare Inflammatory Disease Treatment market size is expected to reach $18.98 billion by 2030 at 5.1%, driven by rising prevalence of autoimmune disorders.
Read More
The rare hematology market is projected to reach $21.25 by 2030, growing at 6.5% CAGR, driven by precision diagnostics and targeted biologics.
Read More
The rare endocrine disease treatment market is projected to reach $17.49 by 2030, growing at 6.7% CAGR, driven by biologics, AI, and telemedicine.
Read More
Rare disease genetic testing market to reach $2.18 bn by 2030 at 13.1% CAGR, driven by rising parental age and inherited genetic mutations.
Read More
Global Rare Disease Diagnostics market size is expected to reach $62.18 billion by 2030 at 10.4%, a surge in rare disease incidence and diagnostics
Read More
The rare disease community app market is projected to reach $1.72 by 2030, growing at 13.2% CAGR, driven by AI, blockchain, wearables, and patient engagement.
Read More
The rare disease clinical trials market is projected to reach $21.34 by 2030, growing at 9.9% CAGR, driven by orphan drug trials, digital health, and precision medicine.
Read More
The rare dermatological disease treatment market is projected to reach $7.51 by 2030, growing at 6.1% CAGR, driven by personalized medicine and digital health.
Read More
Rare Biomarkers Specimen Collection And Stabilization market size is expected to reach $55.35 billion by 2030 at 9.2%, driven by increasing prevalence of cancer.
Read More
Global rapid diagnostics market size is expected to reach $64.79 billion by 2030 at 12.4%, driven by demand for personalized medicine, home testing kits, and AI-integrated diagnostics.
Read More